Deptment of Rheumatology, Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100032, China
Location status: Recruiting
Location contact
Hua Chen, MD
CONTACT
Wen Zhang, MD
CONTACT
NCT Number: NCT01670695
This is an cohort study to investigate the disease course and treatment response of patients with IgG4-related disease.
Interested in participating?
Request Info18 year–75 year
All sexes
Observational
Beijing, Beijing Municipality, 100032, China
Location status: Recruiting
Hua Chen, MD
CONTACT
Wen Zhang, MD
CONTACT
Immunoglobulin G4-related disease (IgG4-RD) is a recently defined emerging clinical entity characterized by tissue infiltration by IgG4-positive plasma cells, tissue fibrosclerosis and elevated serum IgG4 concentration.
In this study, patients with IgG4-RD will be investigated, including clinical presentation, laboratory findings and imaging study. All patients will be treated by standard care and follow-uped for at least 6 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months
Clinical Response is measured by IgG4-RD Responder Index, including organ/site score and serum IgG4 level.
Contact information is provided by the study sponsor or research team.
Peking Union Medical College Hospital
Other
Cohort Study of Patients With IgG4-Related Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06285539
Autoimmune Diseases, Behcet Syndrome
Amsterdam, Netherlands
View Trial DetailsNCT06663618
Autoimmune Diseases, IgG4-related Disease
Beijing, Beijing Municipality, China
View Trial DetailsNCT06497387
Autoimmune Diseases, Connective Tissue Diseases
Wuhan, Hubei, China
View Trial DetailsNCT06497361
Autoimmune Diseases, Connective Tissue Diseases
Wuhan, Hubei, China
View Trial Details